Home
Current Affairs January 2024

What is the correct answer?

4

Which of the following is a risk factor for developing upper urinary tract tumors?

A. obesity

B. consuming artificial sweeteners

C. asbestosis

D. analgesic abuse

Correct Answer :

D. analgesic abuse


analgesic abuse especially phenacetin.

Related Questions

What is the correct answer?

4

Which of the following cystoscopic descriptions of bladder tumors is false?

A. nodular or sessile lesions usually invade muscle

B. papillary bladder tumors are typical of low stage and grade

C. carcinoma in situ appears as a flat, velvety patch

D. sarcomas commonly invade bladder base and ureteral orifices causing obstructions

What is the correct answer?

4

What is the ideal vesical tumor patient for bladder preservation?

A. patients with carcinoma in situ

B. patients with completely resected solitary tumor

C. patients with preserved kidney and liver functions after 2 courses of BCG

D. patients with leiomyosarcoma

What is the correct answer?

4

During women`s life span, what percentage of women will develop keratinizing squamous metaplasia of the bladder?

A. 10%

B. 20%

C. 30%

D. 40%

What is the correct answer?

4

In women, what is the commonest type of cancers occurring in the proximal urethra?

A. adenocarcinoma

B. transitional cell carcinoma

C. squamous cell carcinoma

D. basal cell carcinoma

What is the correct answer?

4

Common benign urethral tumors include all of the following,
EXCEPT:

A. leiomyoma

B. hemangioma

C. fibroepithelial polyp

D. lymphangioma

What is the correct answer?

4

Which of the following statements concerning lymphatic drainage of the male urethra is true?

A. the anterior urethra drains into the inguinal and pelvic nodes

B. the posterior urethra drains into the pelvic nodes

C. the proximal two-thirds drain into the external and internal iliac nodes

D. the distal one-third drains into the obturator nodes

What is the correct answer?

4

Risk factors for recurrence and progression of bladder cancers include the following:

A. multifocality

B. high tumor grade and advanced stage

C. presence of CIS

D. all of the above

What is the correct answer?

4

What might occur while resecting a bladder mass at the posterolateral wall?

A. bladder perforation

B. obturator nerve reflex

C. vesico-ureteral reflux

D. terrible bleeding

What is the correct answer?

4

Bladder cancer patients who once failed BCG vaccine, should:

A. undergo cystectomy

B. try mitomycin c

C. take a second course of BCG

D. take a second course of BCG + quinolones

What is the correct answer?

4

Carcinoma-in-situ of the prostatic urethra mostly occurs at the:

A. mid prostate to the verumontanum at the 5 and 7 oclock positions

B. lateral margins of the prostate at the 10 and 2 oclock positions

C. entire area distal to the urethral crest

D. area between ejaculatory duct openings and prostatic utricle

What is the correct answer?

4

Which of the following is a risk factor for developing upper urinary tract tumors?

A. obesity

B. consuming artificial sweeteners

C. asbestosis

D. analgesic abuse

What is the correct answer?

4

What percentage of bladder cancers is squamous cell type in origin?

A. 2%

B. 5%

C. 70%

D. 90%

What is the correct answer?

4

Which of the following does NOT predispose to bladder cancer?

A. working with organic chemicals and dyes

B. abuse of pain-control medications especially phenacetin

C. exposure to arsenic and aromatic amines

D. schistosomiasis

What is the correct answer?

4

For radical cystectomy, thromboembolism prophylaxis is required:

A. immediately before operation

B. immediately before incision and post-operative for 1 day

C. immediately before incision and post-operative for 15 days

D. immediately before incision and post-operative for 30 days

What is the correct answer?

4

The 5-yr survival rates of non-muscle-invasive bladder cancer are:

A. 40 - 55%

B. 55 - 70%

C. 70 - 85%

D. 85 - 100%

What is the correct answer?

4

Regarding ureteral cancers, what is the commonest part of tumor development?

A. upper ureter

B. middle ureter

C. lower ureter

D. comparable

What is the correct answer?

4

Partial cystectomy for bladder tumors can be performed when the following criterion(a) is(are) met:

A. the lesion is solitary and no associated CIS

B. physically, a surgical margin of 2-cm can be obtained

C. the resected area should be far enough from ureteral orifices and the bladder neck

D. all of the following

What is the correct answer?

4

While resecting a large bladder tumor located at the right lateral wall, the surgeon observes a bladder perforation, what should next step be?

A. continue the procedure as perforations at this site do no harm

B. abort the procedure and leave a urethral catheter

C. convert tumor removal to open method and repair the defect

D. perform abdominal exploration and manage accordingly

What is the correct answer?

4

What is false regarding the symptomatology of urethral cancers?

A. obstructive LUTS are common presentations and occur in association with carcinoma in situ

B. might present as perineal abscesses and fistulae

C. could be asymptomatic

D. venereal diseases increase the risk of urethral cancers

What is the correct answer?

4

What is true regarding inverted papilloma of the bladder?

A. the standard treatment is transurethral resection

B. the prognosis for inverted papilloma is pathetic, with a recurrence rate of approximately 65%

C. the likelihood of synchronous urothelial carcinoma is 26%

D. has been shown to harbor p53 gene mutations

What is the correct answer?

4

Partial penectomy for urethral cancer is indicated in:

A. infiltrative proximal penile urethral carcinomas

B. infiltrative distal penile urethral carcinomas

C. recurrent proximal penile urethral carcinoma after laser resection

D. T3/N2/M0 at bulbar urethra

What is the correct answer?

4

What is NOT a contraindication to BCG treatment?

A. history of pulmonary TB

B. total incontinence

C. immunosuppression

D. impaired renal function

What is the correct answer?

4

What is (are) the classic presentation(s) of bladder cancers?

A. irritative bladder symptoms

B. obstructive bladder symptoms

C. palpable suprapubic mass on physical examination

D. painless profuse hematuria

What is the correct answer?

4

On diagnosing bladder cancers, what advantage does urine cytology has over tumor markers?

A. high specificity

B. high sensitivity

C. high reliability

D. strong validity

What is the correct answer?

4

The treatment of T2/Nx/M0 prostatic urethral cancer is:

A. en bloc resection involving total penectomy, cystoprostatectomy, resection of the pubic rami and urogenital diaphragm, with pelvic lymphadenectomy. In addition, creating a urinary diversion.

B. total penectomy involving removal of the penis, urethra, and penile root

C. partial penectomy involving excision of the malignant lesion with 2-cm margins

D. transurethral resection or fulguration

What is the correct answer?

4

What gene mutation is common in carcinoma-in-situ of urinary bladder?

A. RB

B. cyclin A

C. HRAS

D. CD-44

What is the correct answer?

4

The treatment of muscle-invasive bladder cancer in men includes all of the following, EXCEPT:

A. radical cysto-prostatectomy

B. anterior pelvic exenteration

C. bilateral pelvic lymphadenectomy

D. creation of a urinary diversion

What is the correct answer?

4

While deeply resecting a large bladder tumor, the surgeon noted loss of bladder distension, what should next step be?

A. increase the irrigation fluid and pursue the procedure

B. abort the procedure and leave a urethral catheter

C. perform cystogram and manage accordingly

D. perform abdominal exploration and manage accordingly

What is the correct answer?

4

In what percentages of patients do bilateral upper tract tumors occur either synchronously or metachronously?

A. 0.6 - 2%

B. 2 - 6%

C. 6 - 10%

D. 12 - 16%

What is the correct answer?

4

What type of bladder cancers might be caused by Schistosoma haematobium infection?

A. transitional cell carcinoma

B. squamous cell carcinoma

C. adenocarcinoma

D. small cell carcinoma